Synthesis and antiplatelet activity of gemfibrozil chiral analogues.
暂无分享,去创建一个
M. Baraldi | A. Duranti | B. De Filippis | A. Ammazzalorso | R. Amoroso | F. Vezzalini | P. Tortorella | D. Braghiroli | M. L. Tricca | G. Bettoni | M. Moretti
[1] R. Amoroso,et al. Direct resolution of α-monoalkyl-α-aryloxyacetic acids via ester or imide derivatives , 1998 .
[2] R. Cattley,et al. Peroxisome proliferators alter the expression of estrogen-metabolizing enzymes. , 1997, Biochimie.
[3] S. Kundu,et al. Characterization of an In Vitro Platelet Function Analyzer, PFA-100™ , 1996 .
[4] C. Spencer,et al. Gemfibrozil. A reappraisal of its pharmacological properties and place in the management of dyslipidaemia. , 1996, Drugs.
[5] J. Seki,et al. The anti-platelet actions of FR122047, a novel cyclooxygenase inhibitor. , 1993, European journal of pharmacology.
[6] B. Sobel,et al. Direct Effects of Gemfibrozil on the Fibrinolytic System: Diminution of Synthesis of Plasminogen Activator Inhibitor Type 1 , 1992, Circulation.
[7] F. Loiodice,et al. Stereospecificity of the chloride ion channel: the action of chiral clofibric acid analogues. , 1987, Journal of medicinal chemistry.
[8] Davidr . Evans,et al. Contrasteric carboximide hydrolysis with lithium hydroperoxide , 1987 .
[9] S. Bellucci,et al. Detection of abnormal platelet functions with an in vitro model of primary haemostasis. , 1985, Haemostasis.